Table 3.
Association between events during stay at the ICU and markers measured in COVID-19 patients.
| Event | Analysis | Unit | Event present | Event not present | AUC | P |
|---|---|---|---|---|---|---|
| Dialysis | Yes (13) | No (87) | ||||
| sAXL | Day 1 | ng/ml | 11.7 (9.1–19.6) | 19.3 (13.9–25.2) | 0.021 | |
| ROC curve | 0.301 (0.158–0.443 | 0.029 | ||||
| VTE | Yes (14) | No (86) | ||||
| NE | Day 1 | ng/ml | 40.9 (20.0–66.2) | 83.4 (40.7–143.9) | 0.019 | |
| Delirium | Yes (9) | No (70) | ||||
| Gas6 | Day 1 | ng/ml | 31.1 (23.8–38.5) | 23.2 (16.2–30.3) | 0.033 | |
| ICUAW | Yes (9) | No (91) | ||||
| cfDNA | Day 1 | ng/µl | 699.5 (273.1–1130.4) | 246.6 (139.1–466.9) | 0.019 | |
| ROC curve | 0.786 (0.566–0.909) | 0.009 |
Indicated is the event and significant altered plasma markers. The difference at day 1 or the delta is calculated with Mann–Whitney U and the predictive power of an event by a marker is calculated by the AUC of the ROC curve. Values are considered significant if p < 0.05.
VTE various thromboembolic events, ICUAW Intensive Care Unit Acquired Weakness, ROC receiver operating characteristic, AUC area under the curve.